Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Fresenius Medical Care starts 2025 with strong organic revenue and income growth
-
ReposiTrak Adds 50 Nut Butter Product Suppliers to the Queue for the Rapidly Expanding Food Traceability Network
-
Woof Gang Bakery & Grooming Opens First Store in Wisconsin, Continuing National Expansion Momentum
-
DoorDash Releases First Quarter 2025 Financial Results
-
Seed Oil Free Certified Brands Announced Nationwide
-
A Blast from the Past: The Corolla Hatchback Gets Rowdy with New FX Edition
-
AdaptHealth Corp. Announces First Quarter 2025 Results
-
DigitalOcean Announces First Quarter 2025 Financial Results
-
Perion Announces Conference Participation in May 2025
-
HALEKULANI OKINAWA AND BLUE ZONES® ANNOUNCE EXCLUSIVE LONGEVITY RETREAT
-
Novanta Announces Financial Results for the First Quarter 2025
-
The Brain Aneurysm Foundation Rallies Support Among Lawmakers and Health Agencies to Increase Critical Research Funding for Disease Prevention and Detection
-
Pipedrive to Strengthen Presence in the German Market
-
Leo Cancer Care Particle Therapy Solution Marie is now 510(k) Pending
-
ActiveCampaign Appoints Simon Malkowski as Chief Operating Officer to Drive Operational Excellence
-
Bowhead Specialty Holdings Inc. Reports First Quarter 2025 Results
-
Genius Sports Increases First Quarter Group Revenue and Group Adj. EBITDA by 20% and 188%, Respectively, and Maintains 2025 Outlook for 21% Group Revenue Growth and 20% Group Adj. EBITDA Margin
-
Lithium Ionic Reports Updated Mineral Resource Estimate at its Bandeira Lithium Project, Minas Gerais, Brazil; Significantly Increases Global Mineral Resources in the Lithium Valley
-
Keystone Custom Homes Expands into Virginia Through Strategic Partnership with Southern Development Homes, United by Profit for Purpose
-
Greenbacker’s Cider solar project awarded North American Solar Deal of the Year
-
Siyata Mobile Inc. Publishes Transcript of First Shareholder AMA Video Featuring Core Gaming CEO Aitan Zacharin
-
Dream Finders Announces First Quarter 2025 Results
-
Axcelis Announces Financial Results for First Quarter 2025
-
Upstream Bio Reports First Quarter 2025 Financial Results and Accelerates Guidance on All Clinical Programs
-
Morningstar Introduces Medalist Rating for Semiliquid Funds, Advancing Transparency in Private Markets
-
Aduro Launches Revolutionary Health and Human Performance Platform
-
AI Proteins to Present Key Advances in Miniprotein Therapeutics Development at PEGS Boston 2025
-
Sonoma Biotherapeutics Announces Oral and Poster Presentations at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting
-
Viridian Therapeutics Highlights Recent Progress and Reports First Quarter 2025 Financial Results
-
Human Longevity, Inc., Expands Cancer Prevention Offering by Selecting the ClearNote Health Avantect® Early Detection Pancreatic Cancer Test
-
Tvardi Therapeutics Announces Presentation at the American Thoracic Society 2025 Annual Conference
-
Sandglass Capital Appoints Charles-Antoine Wauters as Director of Research to Support the Firm’s Growing Corporate Distressed Opportunity Set
-
Board Announcement: Jim Lynch Joins Newforma Board
-
Sierra Metals Responds to Alpayana’s Increased Offer; Makes No Recommendation to Shareholders
-
FiscalNote To Participate At Upcoming Investor Conferences
-
WEC Energy Group reports first-quarter results
-
Lantronix to Participate in the 22nd Annual Craig-Hallum Institutional Investor Conference on May 28, 2025
-
Gatik Strengthens Leadership Team With Key Appointments, Setting the Stage for Rapid Growth Amidst Accelerating Commercial Demand
-
AmericanTCS Strengthens American Trust Retirement Leadership with Two Key Appointments
-
E Source Acquires ILLUME Advising to Boost Program Evaluation Capabilities
-
Silver Storm Announces Acquisition of Till Capital
-
FlowPath Launches Work Order AI Automation Package, Setting a New Standard for Facility Management Software
-
Transpire Bio Announces R&D and Manufacturing Expansion
-
ScaleReady awards a $300,000 G-Rex® Grant to A2 Biotherapeutics, Inc.
-
Data is revolutionizing agriculture by enabling better decisions
-
Zetagen Therapeutics Announces Successful Completion of Enrollment in Phase 2a Clinical Study of ZetaMet™ (Zeta-BC-003) Metastatic Breast Cancer
-
American Pride Bank Launches Third-Party Origination Mortgage
-
Standard Reporting Underestimates the Value of Office Furniture Reuse
-
Promega Madison Achieves ISO 14001 Certification for Environmental Management
-
Plug Power Closes $525 Million Secured Credit Facility with Yorkville Advisors


